BioSpace News Archive

GuideWell Mutual Holding Corporation announced that Sylvia Mathews Burwell has been named to the company’s board of directors.

Koch’s Personal Medical Feat Drove Fundraiser Benefitting Underserved Patients

REGENXBIO Inc. announced that it has received an accelerated license payment of $100 million under its license agreement (the License Agreement) with AveXis, Inc.

Five Prime Therapeutics, Inc., today announced that Aron Knickerbocker, Chief Executive Officer, will present at the Goldman Sachs 39th Annual Global Healthcare Conference.

Canopy Growth Corporatio and its subsidiary, Bedrocan Canada Inc. (“BC”) are pleased to announce that they have reached an agreement (the “Agreement”) with Bedrocan International BV

Bristol-Myers Squibb Company will take part in Goldman Sachs 39th Annual Global Healthcare Conference.

HyperBranch Medical Technology, Inc. announced that on June 8, 2018, after a two-week trial in federal district court in Wilmington, Delaware, an 8-member jury found in favor of HyperBranch on all remaining claims and legal defenses at issue in a patent infringement lawsuit filed by Integra LifeSciences Corp., Integra LifeSciences Sales LLC, Confluent Surgical, Inc. and Incept LLC (collectively, “Integra”).

Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics, announced today that it has closed its previously announced underwritten public offering (the “Offering”) of 6,210,000 common shares

At first glance it may appear that the United States holds the upper hand at the Trump-Kim Jong Un summit: a huge nuclear arsenal versus a few bombs and limited delivery capacity.

WebMD Health Corp. announced that it has acquired Jobson Healthcare Information (JHI).